Market & Portfolio Update - January 2020
Market & Portfolio Update - January 2020
The first month of 2020 saw volatility return to global markets, first with the attack by the US on Iran, followed by the recent health scare of the coronavirus. While global markets predominantly ended where they started in local terms, a falling NZ dollar, increased the value of unhedged overseas assets for NZ investors.
Long term interest rates around the world were lower by a quarter percent as investors retreated to safer government bonds in anticipation of the potential negative impact to global growth by the coronavirus.
At the end of 2018 we set up the NZ Innovation Booster partnership with Victoria University’s research arm, VicLink. To date, the partnership has invested in four exciting companies and this month we added two more; cancer diagnostics company Ferronova and antimicrobial coatings business Inhibit. We are very excited to be investing in NZ ideas that have the potential to transform their discoveries into products or services that have a real benefit to society.
RBNZ Cuts OCR to 2.5%: What It Means for Borrowers
On 8 October 2025, the Reserve Bank of New Zealand (RBNZ) cut the Official Cash Rate (OCR) by 50 basis points to 2.5%, its largest move in more than three years.
